Form 4: Merit Medical Director Receives RSU Grant

Director F. Ann Millner was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.

Summary

• Director F. Ann Millner acquired 3,457 restricted stock units (RSUs) on May 18, 2026.
• The grant was issued under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
• Following this transaction, the director's total beneficial ownership of common stock is 38,000 shares.
• The RSUs are scheduled to vest on May 3, 2027, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of the RSUs is contingent upon the director's continued service to the company through the vesting date.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the medical device industry to ensure board alignment with shareholder interests.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices among mid-cap medical technology companies.
• The vesting period of approximately one year is typical for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders; reflects standard board compensation practices.

Next Steps

• Vesting of the 3,457 RSUs on May 3, 2027.

Key Dates

Keywords

Merit Medical Systems, MMSI, Form 4, Director Compensation, Restricted Stock Units, Equity Incentive Plan